Company Filing History:
Years Active: 2020-2023
Title: Linde Miles: Innovator in Oncotherapy
Introduction
Linde Miles is a prominent inventor based in New York, NY, who has made significant contributions to the field of oncotherapy. With a total of three patents to her name, she is recognized for her innovative approaches to cancer treatment.
Latest Patents
One of her latest patents focuses on the Seneca Valley Virus (SVV) cellular receptor targeted oncotherapy. This patent outlines a method for selecting cancer patients for treatment with SVV by determining the expression of ANTXR1 in cancerous tissue. If normal or elevated levels of ANTXR1 expression are detected, the patient is designated as a candidate for treatment with SVV. Additionally, the patent discloses a method for treating cancer patients with SVV, showcasing her commitment to advancing cancer therapies.
Career Highlights
Linde Miles is affiliated with the Memorial Sloan Kettering Cancer Center, where she continues her research and development in cancer treatment. Her work is pivotal in the ongoing fight against cancer, and her innovative methods are paving the way for new therapeutic options.
Collaborations
Throughout her career, Linde has collaborated with esteemed colleagues such as John Poirier and Charles Rudin. These partnerships have enhanced her research and contributed to the advancement of oncological therapies.
Conclusion
Linde Miles is a trailblazer in the field of oncotherapy, with her innovative patents and dedication to cancer research. Her work at Memorial Sloan Kettering Cancer Center exemplifies her commitment to improving patient outcomes through targeted therapies.